FFA
GNOM icon

Farther Finance Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Farther Finance Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,000
Closed -$41.6K – 4050
2024
Q2 		$41.6K Sell
1,000
-174
-15% -$7.27K ﹤0.01% 1497
2024
Q1 		$53.4K Buy
1,174
+174
+17% +$7.93K ﹤0.01% 1164
2023
Q4 		$46.2K Hold
1,000
– – ﹤0.01% 1060
2023
Q3 		$40.7K Buy
+1,000
New +$45.5K 0.01% 836

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Farther Finance Advisors's GNOM Position: Q3 2024 in Review

Farther Finance Advisors sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2024, closing a stake of 1,000 shares — an estimated $41.6K sold.

Farther Finance Advisors first reported a position in GNOM in Q3 2023 and held it in 4 quarters. The position peaked at $53.4K in Q1 2024. 64 funds tracked by Wall St. Rank hold GNOM as of Q3 2024.

  • Farther Finance Advisors reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
  • Farther Finance Advisors sold 1,000 Global X Genomics & Biotechnology ETF shares in Q3 2024, an estimated $41.6K.
  • Farther Finance Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q3 2023 and held it in 4 quarters.
  • Farther Finance Advisors's Global X Genomics & Biotechnology ETF position peaked at $53.4K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2024.

Based on Farther Finance Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.